High ROIC Stocks
RMD is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
RESMED INC (RMD) Stock Price & Overview
NYSE:RMD • US7611521078
Current stock price
228.12 USD
+3.4 (+1.51%)
At close:
227.815 USD
-0.31 (-0.13%)
After Hours:
The current stock price of RMD is 228.12 USD. Today RMD is up by 1.51%. In the past month the price increased by 0.31%. In the past year, price increased by 7.14%.
RMD Key Statistics
52-Week Range209.31 - 293.81
Current RMD stock price positioned within its 52-week range.
1-Month Range218.39 - 234.905
Current RMD stock price positioned within its 1-month range.
- Market Cap
- 33.233B
- P/E
- 22.19
- Fwd P/E
- 18.58
- EPS (TTM)
- 10.28
- Dividend Yield
- 1.05%
RMD Stock Performance
Today
+1.51%
1 Week
-0.33%
1 Month
+0.31%
3 Months
-11.44%
Longer-term
6 Months -14.91%
1 Year +7.14%
2 Years +6.60%
3 Years -5.33%
5 Years +21.36%
10 Years +308.82%
RMD Stock Chart
RMD Stock Screens
RMD currently appears in the following ChartMill screener lists.
High Free Cash Flow Stocks
RMD is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
Dividend Growth Stocks
RMD is part of our Dividend Growth Stocks screen, indicating it has a reliable dividend with grows strongly
High Quality Stocks
RMD is part of our High Quality Stocks screen, meaning it meets strict criteria for profitability, capital efficiency, and long-term growth consistency.
GARP Stocks
RMD is part of our growth-at-reasonable-price stock list, indicating it is growing while not too expensive.
Highest Analyst Upside Stocks
RMD is part of our highest analyst upside stock list, indicating analysts have a price target way above the current price.
Quality At A Fair Price Stocks
RMD appears in our Quality At A Fair Price Stocks screen. This means the stock combines high margins, strong cash conversion, solid returns on capital, healthy debt control, and a reasonable free cash flow valuation, which are all traits often associated with a Terry Smith-style investing approach.
RMD Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to RMD. When comparing the yearly performance of all stocks, RMD is a bad performer in the overall market: 75.34% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
RMD Fundamental Analysis
ChartMill assigns a fundamental rating of 8 / 10 to RMD. RMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
RMD Earnings
On January 29, 2026 RMD reported an EPS of 2.81 and a revenue of 1.42B. The company beat EPS expectations (2.15% surprise) and beat revenue expectations (0.91% surprise).
Next Earnings DateApr 30, 2026
Last Earnings DateJan 29, 2026
PeriodQ2 / 2026
EPS Reported$2.81
Revenue Reported1.423B
EPS Surprise 2.15%
Revenue Surprise 0.91%
RMD Forecast & Estimates
25 analysts have analysed RMD and the average price target is 302.83 USD. This implies a price increase of 32.75% is expected in the next year compared to the current price of 228.12.
For the next year, analysts expect an EPS growth of 16.35% and a revenue growth 10.03% for RMD
Analysts
Analysts73.6
Price Target302.83 (32.75%)
EPS Next Y16.35%
Revenue Next Year10.03%
RMD Groups
Sector & Classification
Sector
Health Care Sub-Industry
Health Care Equipment RMD Financial Highlights
Over the last trailing twelve months RMD reported a non-GAAP Earnings per Share(EPS) of 10.28. The EPS increased by 16.29% compared to the year before.
Income Statements
Revenue(TTM)5.40B
Net Income(TTM)1.49B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.53% | ||
| ROA | 17.47% | ||
| ROE | 23.51% | ||
| Debt/Equity | 0.06 |
Chartmill High Growth Momentum
EPS Q2Q%15.64%
Sales Q2Q%10.98%
EPS 1Y (TTM)16.29%
Revenue 1Y (TTM)9.57%
RMD Ownership
Ownership
Inst Owners68.64%
Shares145.68M
Float144.94M
Ins Owners0.49%
Short Float %8.2%
Short Ratio10.62
RMD Latest News, Press Relases and Analysis
4 days ago - By: Chartmill
RMD Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 15.41 | 165.895B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.92 | 162.696B | ||
| SYK | STRYKER CORP | 22.7 | 129.593B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.42 | 94.254B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.88 | 45.576B | ||
| IDXX | IDEXX LABORATORIES INC | 39.79 | 45.265B | ||
| BDX | BECTON DICKINSON AND CO | 11.62 | 44.083B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.45 | 33.4B | ||
| DXCM | DEXCOM INC | 25.16 | 23.565B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.18 | 18.347B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 31.42 | 14.184B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RMD
Company Profile
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Company Info
IPO: 1995-06-01
RESMED INC
9001 Spectrum Center Blvd
San Diego CALIFORNIA 92123 US
CEO: MichaelJ.Farrell
Employees: 10600
Phone: 18587462400
RESMED INC / RMD FAQ
What does RESMED INC do?
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
What is the stock price of RESMED INC today?
The current stock price of RMD is 228.12 USD. The price increased by 1.51% in the last trading session.
Does RESMED INC pay dividends?
RESMED INC (RMD) has a dividend yield of 1.05%. The yearly dividend amount is currently 2.12.
How is the ChartMill rating for RESMED INC?
RMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 8 out of 10.
What is the analyst forecast for RMD stock?
25 analysts have analysed RMD and the average price target is 302.83 USD. This implies a price increase of 32.75% is expected in the next year compared to the current price of 228.12.
When is the next dividend date for RESMED INC (RMD)?
The next ex-dividend date for RESMED INC (RMD) is February 12, 2026.
Can you provide the ownership details for RMD stock?
You can find the ownership structure of RESMED INC (RMD) on the Ownership tab.